Literature DB >> 24603307

Effect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial.

Felix Mahfoud1, Daniel Urban2, Desiree Teller3, Dominik Linz4, Philipp Stawowy3, Jan-Hendrik Hassel3, Peter Fries5, Stephan Dreysse3, Ernst Wellnhofer3, Günther Schneider5, Arno Buecker5, Christopher Schneeweis3, Adelina Doltra3, Markus P Schlaich6, Murray D Esler6, Eckart Fleck3, Michael Böhm4, Sebastian Kelle3.   

Abstract

AIMS: Sympathetic stimulation induces left ventricular hypertrophy and is associated with increased cardiovascular risk. Catheter-based renal denervation (RDN) has been shown to reduce sympathetic outflow and blood pressure (BP). The present multi-centre study aimed to investigate the effect of RDN on anatomic and functional myocardial parameters, assessed by cardiac magnetic resonance (CMR), in patients with resistant hypertension. METHODS AND
RESULTS: Cardiac magnetic resonance was performed in 72 patients (mean age 66 ± 10 years) with resistant hypertension (55 patients underwent RDN, 17 served as controls) at baseline and after 6 months. Clinical data and CMR results were analysed blindly. Renal denervation significantly reduced systolic and diastolic BP by 22/8 mm Hg and left ventricular mass index (LVMI) by 7.1% (46.3 ± 13.6 g/m(1.7) vs. 43.0 ± 12.6 g/m(1.7), P < 0.001) without changes in the control group (41.9 ± 10.8 g/m(1.7) vs. 42.0 ± 9.7 g/m(1.7), P = 0.653). Ejection fraction (LVEF) in patients with impaired LVEF at baseline (<50%) significantly increased after RDN (43% vs. 50%, P < 0.001). Left ventricular circumferential strain as a surrogate of diastolic function in the subgroup of patients with reduced strain at baseline increased by 21% only in the RDN group (-14.8 vs. -17.9; P = 0.001) and not in control patients (-15.5 vs. -16.4, P = 0.508).
CONCLUSIONS: Catheter-based RDN significantly reduced BP and LVMI and improved EF and circumferential strain in patients with resistant hypertension, occurring partly BP independently. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2014. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Cardiovascular magnetic resonance; Circumferential strain; Left ventricular hypertrophy; Renal nerve ablation; Resistant hypertension

Mesh:

Substances:

Year:  2014        PMID: 24603307     DOI: 10.1093/eurheartj/ehu093

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  52 in total

1.  Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension.

Authors:  Luca Donazzan; Felix Mahfoud; Sebastian Ewen; Christian Ukena; Bodo Cremers; Carl-Martin Kirsch; Dirk Hellwig; Tareq Eweiwi; Samer Ezziddin; Murray Esler; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2015-10-22       Impact factor: 5.460

Review 2.  Reductions of left ventricular mass and atrial size following renal denervation: a meta-analysis.

Authors:  Dasheng Lu; Kai Wang; Qian Liu; Shengchan Wang; Qi Zhang; Qijun Shan
Journal:  Clin Res Cardiol       Date:  2016-02-02       Impact factor: 5.460

Review 3.  Modulation of renal sympathetic innervation: recent insights beyond blood pressure control.

Authors:  Dominik Linz; Mathias Hohl; Adrian D Elliott; Dennis H Lau; Felix Mahfoud; Murray D Esler; Prashanthan Sanders; Michael Böhm
Journal:  Clin Auton Res       Date:  2018-02-10       Impact factor: 4.435

4.  Renal Denervation to Treat Heart Failure.

Authors:  Thomas E Sharp; David J Lefer
Journal:  Annu Rev Physiol       Date:  2020-10-19       Impact factor: 19.318

Review 5.  Renal Denervation for Resistant Hypertension: Past, Present, and Future.

Authors:  Christian Ott; Roland E Schmieder
Journal:  Curr Hypertens Rep       Date:  2015-08       Impact factor: 5.369

Review 6.  Renal denervation for resistant hypertension.

Authors:  Giuseppe Coppolino; Anna Pisano; Laura Rivoli; Davide Bolignano
Journal:  Cochrane Database Syst Rev       Date:  2017-02-21

Review 7.  Renal sympathetic denervation in therapy resistant hypertension - pathophysiological aspects and predictors for treatment success.

Authors:  Karl Fengler; Karl Philipp Rommel; Thomas Okon; Gerhard Schuler; Philipp Lurz
Journal:  World J Cardiol       Date:  2016-08-26

Review 8.  A perspective on sympathetic renal denervation in chronic congestive heart failure.

Authors:  Raef Madanieh; Mohammed El-Hunjul; Hassan Alkhawam; Constantine E Kosmas; Abed Madanieh; Timothy J Vittorio
Journal:  Heart Fail Rev       Date:  2016-01       Impact factor: 4.214

9.  Percutaneous renal artery denervation in patients with chronic systolic heart failure: A randomized controlled trial.

Authors:  Jun-Qing Gao; Wei Yang; Zong-Jun Liu
Journal:  Cardiol J       Date:  2018-04-03       Impact factor: 2.737

10.  Long-term effects of multielectrode renal denervation on cardiac adaptations in resistant hypertensive patients with left ventricular hypertrophy.

Authors:  C Tsioufis; V Papademetriou; K Dimitriadis; A Kasiakogias; A Kordalis; E Andrikou; A Milkas; I Liatakis; E O-Y Lau; D Tousoulis
Journal:  J Hum Hypertens       Date:  2016-01-28       Impact factor: 3.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.